Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
25. marts 2026 Meddelelse nr. 4 Indkaldelse til ordinær generalforsamling i Pharma Equity Group A/S Bestyrelsen indkalder hermed til den ordinære generalforsamling i Pharma Equity Group A/S (“PEG”...
-
25 March 2026 Announcement no. 4 Notice convening the annual general meeting in Pharma Equity Group A/S The board of directors hereby convenes the annual general meeting in Pharma Equity Group A/S...
-
25 March 2026 Announcement no. 3 Pharma Equity Group A/S - Årsrapport 2025 Pharma Equity Group A/S - Årsrapport 2025 - året i hovedtræk Bestyrelsen for Pharma Equity Group A/S har dags dato...
-
25 March 2026 Announcement no. 3 Pharma Equity Group A/S - Annual Report 2025 Pharma Equity Group A/S - Annual Report 2025 – Highlights of the year Today, the Board of Directors of Pharma Equity...
-
OPDATERING AF FINANSKALENDER FOR 2026 Hørsholm 18. marts 2026 Selskabsmeddelelse nr. 2 Pharma Equity Group A/S foretager en rettelse til finanskalenderen for 2026. Offentliggørelsen af...
-
UPDATE OF THE FINANCIAL CALENDAR FOR 2026 Hørsholm 18 March 2026 Company announcement no 2 Pharma Equity Group A/S updates its financial calendar for 2026. For technical reasons, the publication of...
-
ORRIGERENDE INFORMATION (SUPPLEMENTARY INFORMATION) TIL ÅRSRAPPORTEN FOR 2024 OG DELÅRSRAPPORTEN FOR 1. HALVÅR 2025 Hørsholm 26. februar 2026 Selskabsmeddelelse nr. 1 Pharma Equity Group A/S...
-
SUPPLEMENTARY INFORMATION (CORRECTIVE INFORMATION) TO THE ANNUAL REPORT 2024 AND THE INTERIM REPORT FOR H1 2025 Hørsholm 26 February 2026 Company announcement #1 Pharma Equity Group A/S (the...
-
3. februar 2026 Pressemeddelelse Pharma Equity GroupFinans Kalender for 2026 4. martsFrist for aktionærforslag - Ordinær generalforsamling 18. marts Årsrapport 2025 16. aprilOrdinær...
-
3 February 2026 News Release Pharma Equity Group2026 Financial Calendar March 4Deadline for shareholder proposals - Annual General meeting March 18 Annual Report 2025 April 16Annual General...